RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 151 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,880 | -7.9% | 11,000 | +10.0% | 0.00% | – |
Q2 2023 | $12,900 | -2.3% | 10,000 | 0.0% | 0.00% | – |
Q1 2023 | $13,200 | -12.0% | 10,000 | 0.0% | 0.00% | – |
Q4 2022 | $15,000 | +25.0% | 10,000 | 0.0% | 0.00% | – |
Q3 2022 | $12,000 | +9.1% | 10,000 | -6.1% | 0.00% | – |
Q2 2022 | $11,000 | -65.6% | 10,646 | 0.0% | 0.00% | – |
Q1 2022 | $32,000 | +10.3% | 10,646 | 0.0% | 0.00% | – |
Q4 2021 | $29,000 | -23.7% | 10,646 | 0.0% | 0.00% | – |
Q3 2021 | $38,000 | -11.6% | 10,646 | +6.5% | 0.00% | – |
Q2 2021 | $43,000 | +26.5% | 10,000 | 0.0% | 0.00% | – |
Q1 2021 | $34,000 | -2.9% | 10,000 | 0.0% | 0.00% | – |
Q4 2020 | $35,000 | +1650.0% | 10,000 | +1242.3% | 0.00% | – |
Q2 2016 | $2,000 | 0.0% | 745 | -3.6% | 0.00% | – |
Q1 2016 | $2,000 | 0.0% | 773 | +3.6% | 0.00% | – |
Q4 2015 | $2,000 | -87.5% | 746 | -88.9% | 0.00% | – |
Q3 2015 | $16,000 | -73.3% | 6,746 | -64.0% | 0.00% | – |
Q2 2015 | $60,000 | -6.2% | 18,721 | +4.0% | 0.00% | – |
Q1 2015 | $64,000 | +60.0% | 18,000 | 0.0% | 0.00% | – |
Q4 2014 | $40,000 | +17.6% | 18,000 | 0.0% | 0.00% | – |
Q3 2014 | $34,000 | – | 18,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 1,847,087 | $4,119,000 | 3.26% |
Sio Capital Management, LLC | 1,333,696 | $2,974,000 | 1.52% |
Boxer Capital, LLC | 700,000 | $1,561,000 | 1.38% |
Palo Alto Investors LP | 5,386,534 | $12,012,000 | 0.91% |
ACUTA CAPITAL PARTNERS, LLC | 747,748 | $1,667,000 | 0.80% |
SENZAR ASSET MANAGEMENT, LLC | 1,443,003 | $3,217,897,000 | 0.70% |
Ghost Tree Capital, LLC | 800,000 | $1,784,000 | 0.52% |
NEA Management Company, LLC | 3,243,150 | $7,232,000 | 0.38% |
Rhenman & Partners Asset Management AB | 850,000 | $1,896,000 | 0.34% |
Rock Springs Capital Management LP | 1,750,000 | $3,903,000 | 0.29% |